539730 — Fredun Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapHigh Flyer

Annual balance sheet for Fredun Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	C2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	21.3	162	55.5	71.3	1,195
Net Total Accounts Receivable
Net Total Receivables	1,035	491	752	1,778	936
Total Inventory
Total Other Current Assets
Total Current Assets	1,526	2,162	2,572	4,280	4,982
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	323	386	462	525	1,176
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,870	2,573	3,076	4,874	6,421
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	738	1,397	1,668	3,281	2,969
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	1,189	1,609	1,861	3,460	3,640
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	681	964	1,215	1,414	2,781
Total Liabilities & Shareholders' Equity	1,870	2,573	3,076	4,874	6,421
Total Common Shares Outstanding